• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非阻塞性冠状动脉疾病性心肌梗死。

Myocardial infarction with non-obstructive coronary artery disease.

机构信息

Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

出版信息

EuroIntervention. 2021 Dec 3;17(11):e875-e887. doi: 10.4244/EIJ-D-21-00426.

DOI:10.4244/EIJ-D-21-00426
PMID:34870600
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9724940/
Abstract

As a result of the increased use of coronary angiography in acute myocardial infarction in the last two decades, myocardial infarction with non-obstructive coronary arteries (MINOCA) has received growing attention in everyday clinical practice. At the same time, research interest in MINOCA has increased significantly. MINOCA is a heterogeneous disease entity seen in 5-10% of all patients with myocardial infarction, especially in women. Clinically, MINOCA may be difficult to distinguish from other non-ischaemic conditions that can cause similar symptoms and myocardial injury. There is still some confusion around the diagnosis, investigation and management of patients with MINOCA. The present review summarises the current knowledge of MINOCA regarding epidemiology, pathophysiology, investigation, and treatment, with a special focus on imaging modalities. In addition, remaining important knowledge gaps are highlighted.

摘要

由于在过去二十年中冠状动脉造影术在急性心肌梗死中的应用增加,非阻塞性冠状动脉心肌梗死(MINOCA)在日常临床实践中受到越来越多的关注。与此同时,MINOCA 的研究兴趣显著增加。MINOCA 是一种异质性疾病实体,见于所有心肌梗死患者的 5-10%,尤其是女性。临床上,MINOCA 可能难以与其他可引起类似症状和心肌损伤的非缺血性疾病区分。MINOCA 患者的诊断、检查和治疗仍存在一些混淆。本综述总结了 MINOCA 在流行病学、病理生理学、检查和治疗方面的最新知识,特别关注影像学方法。此外,还强调了仍然存在的重要知识空白。

相似文献

1
Myocardial infarction with non-obstructive coronary artery disease.非阻塞性冠状动脉疾病性心肌梗死。
EuroIntervention. 2021 Dec 3;17(11):e875-e887. doi: 10.4244/EIJ-D-21-00426.
2
Imaging patients with myocardial infarction with non-obstructive coronary arteries (MINOCA).对非阻塞性冠状动脉心肌梗死(MINOCA)患者进行影像学检查。
Heart. 2024 Jan 10;110(3):209-217. doi: 10.1136/heartjnl-2023-322835.
3
Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA): A Review of the Current Position.非阻塞性冠状动脉心肌梗死(MINOCA):当前状况综述。
Cardiology. 2020;145(9):543-552. doi: 10.1159/000509100. Epub 2020 Aug 4.
4
Pathophysiology and diagnostic pathway of myocardial infarction with non-obstructive coronary arteries.非阻塞性冠状动脉心肌梗死的病理生理学和诊断途径。
J Cardiol. 2024 Jan;83(1):17-24. doi: 10.1016/j.jjcc.2023.07.014. Epub 2023 Jul 29.
5
Myocardial bridging is significantly associated to myocardial infarction with non-obstructive coronary arteries.心肌桥与非阻塞性冠状动脉心肌梗死显著相关。
Eur Heart J Acute Cardiovasc Care. 2022 Jun 22;11(6):501-507. doi: 10.1093/ehjacc/zuac047.
6
Coronary artery thromboembolism as a cause of myocardial infarction with non-obstructive coronary arteries (MINOCA).冠状动脉血栓栓塞作为非阻塞性冠状动脉心肌梗死(MINOCA)的病因。
Hellenic J Cardiol. 2024 Sep-Oct;79:70-83. doi: 10.1016/j.hjc.2024.05.001. Epub 2024 May 31.
7
Myocardial infarction with non-obstructive coronary arteries (MINOCA): Intracoronary imaging-based diagnosis and management.非阻塞性冠状动脉心肌梗死(MINOCA):基于冠状动脉内影像学的诊断和治疗。
J Cardiol. 2021 May;77(5):444-451. doi: 10.1016/j.jjcc.2021.01.001. Epub 2021 Jan 16.
8
Coronary Artery Ectasia in the Pathophysiology of Myocardial Infarction With Nonobstructive Coronary Arteries.冠状动脉扩张在非阻塞性冠状动脉心肌梗死的病理生理学中的作用。
Am J Cardiol. 2022 May 15;171:28-31. doi: 10.1016/j.amjcard.2022.01.043. Epub 2022 Mar 11.
9
Myocardial Infarction with Nonobstructive Coronary Arteries.非阻塞性冠状动脉所致心肌梗死
Annu Rev Med. 2023 Jan 27;74:171-188. doi: 10.1146/annurev-med-042921-111727. Epub 2022 Sep 30.
10
Presentation, Clinical Profile, and Prognosis of Young Patients With Myocardial Infarction With Nonobstructive Coronary Arteries (MINOCA): Results From the VIRGO Study.非阻塞性冠状动脉心肌梗死(MINOCA)年轻患者的临床表现、临床特征和预后:VIRGO 研究结果。
J Am Heart Assoc. 2018 Jun 28;7(13):e009174. doi: 10.1161/JAHA.118.009174.

引用本文的文献

1
The Pathophysiology of Cardiac Troponin Release and the Various Circulating Cardiac Troponin Forms-Potential Clinical Implications.心肌肌钙蛋白释放的病理生理学及各种循环心肌肌钙蛋白形式——潜在的临床意义
J Clin Med. 2025 Jun 14;14(12):4241. doi: 10.3390/jcm14124241.
2
Myocardial ischemia in nonobstructive coronary arteries: A review of diagnostic dilemmas, current perspectives, and emerging therapeutic innovations.非阻塞性冠状动脉疾病中的心肌缺血:诊断困境、当前观点及新兴治疗创新综述
World J Cardiol. 2025 May 26;17(5):106541. doi: 10.4330/wjc.v17.i5.106541.
3
Myocardial infarction with nonobstructive coronary arteries (MINOCA): a narrative review.非阻塞性冠状动脉心肌梗死(MINOCA):一篇叙述性综述。
Eur J Med Res. 2025 Jun 2;30(1):443. doi: 10.1186/s40001-025-02703-3.
4
Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis.女性急性冠状动脉综合征的抗血栓药物:性别调整治疗及随机临床试验中的女性代表性。欧洲经皮心血管介入协会(EAPCI)和欧洲心脏病学会血栓形成工作组的临床共识声明。
EuroIntervention. 2025 Jun 16;21(12):e655-e667. doi: 10.4244/EIJ-D-24-00876.
5
Evaluation of the Relationship Between Aortic Stiffness and Elasticity and Left Ventricular Functional Parameters in Patients with ANOCA Using CCTA.使用心脏计算机断层血管造影术(CCTA)评估无阻塞性冠状动脉疾病(ANOCA)患者的主动脉僵硬度、弹性与左心室功能参数之间的关系。
Int J Gen Med. 2025 May 5;18:2439-2447. doi: 10.2147/IJGM.S508938. eCollection 2025.
6
Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA): Current Insights into Pathophysiology, Diagnosis, and Management.非阻塞性冠状动脉心肌梗死(MINOCA):病理生理学、诊断及管理的当前见解
Diagnostics (Basel). 2025 Apr 7;15(7):942. doi: 10.3390/diagnostics15070942.
7
Prognostic significance of individual COVADIS criteria in patients undergoing acetylcholine provocation testing.乙酰胆碱激发试验患者个体COVADIS标准的预后意义
EuroIntervention. 2025 Mar 17;21(6):e296-e306. doi: 10.4244/EIJ-D-24-00832.
8
The Value of Clinical Decision Support in Healthcare: A Focus on Screening and Early Detection.临床决策支持在医疗保健中的价值:聚焦筛查与早期检测
Diagnostics (Basel). 2025 Mar 6;15(5):648. doi: 10.3390/diagnostics15050648.
9
Sex-Related Differences in the Prognostic Role of Acetylcholine Provocation Testing.乙酰胆碱激发试验预后作用中的性别差异
J Am Heart Assoc. 2025 Mar 4;14(5):e037942. doi: 10.1161/JAHA.124.037942. Epub 2025 Feb 25.
10
Specificities of Myocardial Infarction and Heart Failure in Women.女性心肌梗死与心力衰竭的特异性
J Clin Med. 2024 Dec 2;13(23):7319. doi: 10.3390/jcm13237319.

本文引用的文献

1
Comparison of Patients With Nonobstructive Coronary Artery Disease With Versus Without Myocardial Infarction (from the VA Clinical Assessment Reporting and Tracking [CART] Program).比较有心肌梗死和无心肌梗死的非阻塞性冠状动脉疾病患者(来自 VA 临床评估报告和跟踪 [CART] 计划)。
Am J Cardiol. 2021 May 1;146:1-7. doi: 10.1016/j.amjcard.2021.01.015. Epub 2021 Feb 1.
2
Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease.心肌梗死且无阻塞性冠状动脉疾病患者的抗血小板治疗。
Heart. 2021 Nov;107(21):1739-1747. doi: 10.1136/heartjnl-2020-318045. Epub 2021 Jan 27.
3
Effect of Secondary Prevention Medication on the Prognosis in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease.非阻塞性冠状动脉疾病心肌梗死患者二级预防药物治疗对预后的影响。
J Cardiovasc Pharmacol. 2020 Dec;76(6):678-683. doi: 10.1097/FJC.0000000000000918.
4
Pharmacological therapy for the prevention of cardiovascular events in patients with myocardial infarction with non-obstructed coronary arteries (MINOCA): Insights from a multicentre national registry.心梗伴非阻塞性冠状动脉患者(MINOCA)的心血管事件预防的药物治疗:多中心国家注册研究的结果。
Int J Cardiol. 2021 Mar 15;327:9-14. doi: 10.1016/j.ijcard.2020.11.040. Epub 2020 Nov 23.
5
Randomized evaluation of beta blocker and ACE-inhibitor/angiotensin receptor blocker treatment in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA-BAT): Rationale and design.随机评估β受体阻滞剂和 ACE 抑制剂/血管紧张素受体阻滞剂治疗非阻塞性冠状动脉心肌梗死患者(MINOCA-BAT):原理与设计。
Am Heart J. 2021 Jan;231:96-104. doi: 10.1016/j.ahj.2020.10.059. Epub 2020 Oct 24.
6
Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of Myocardial Infarction With Nonobstructive Coronary Arteries in Women.冠状动脉光学相干断层成像和心脏磁共振成像在女性非阻塞性冠状动脉性心肌梗死中的应用。
Circulation. 2021 Feb 16;143(7):624-640. doi: 10.1161/CIRCULATIONAHA.120.052008. Epub 2020 Nov 14.
7
Use of the new Lake Louise Criteria improves CMR detection of atypical forms of acute myocarditis.采用新的路易斯湖标准可提高心脏磁共振成像(CMR)对非典型急性心肌炎的检测能力。
Int J Cardiovasc Imaging. 2021 Apr;37(4):1395-1404. doi: 10.1007/s10554-020-02097-9. Epub 2020 Nov 15.
8
OCT and CMR for the Diagnosis of Patients Presenting With MINOCA and Suspected Epicardial Causes.OCT 和 CMR 用于诊断以 MINOCA 为表现且疑似心外膜原因的患者。
JACC Cardiovasc Imaging. 2020 Dec;13(12):2619-2631. doi: 10.1016/j.jcmg.2020.05.045. Epub 2020 Aug 19.
9
Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update.标准化心血管磁共振成像(CMR)协议:2020 年更新。
J Cardiovasc Magn Reson. 2020 Feb 24;22(1):17. doi: 10.1186/s12968-020-00607-1.
10
Secondary Prevention Medical Therapy and Outcomes in Patients With Myocardial Infarction With Non-Obstructive Coronary Artery Disease.非阻塞性冠状动脉疾病所致心肌梗死患者的二级预防药物治疗及预后
Front Pharmacol. 2020 Jan 31;10:1606. doi: 10.3389/fphar.2019.01606. eCollection 2019.